ALERTS: DISTRIBUTION - FRANCE - OVERSEAS - HEALTH - EXCLUSIVE DISTRIBUTION - EXCLUSIVE RIGHTS

Exclusive distribution: The French Competition Authority issues a new decision sanctioning the maintenance, after the entry into force of the Lurel Act, of an exclusive import agreement in the overseas communities (bioMérieux, Guyana Medical Service)

KEYWORDS
Reference

Fr. Comp. Auth., May 29th, 2019, Press Comm., Dec. 19-D-11

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. On May 29, 2019, the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

This document is protected by copyright laws and international copyright treaties. Non-authorised use of this document constitutes a violation of the publisher's rights and may be punished by up to 3 years imprisonment and up to a € 300 000 fine (Art. L 335-2 Code de la Propriété Intellectuelle). Personal use of this document is authorised within the limits of Art. L 122-5 CPI and DRM protection.

PDF Version

Author

  • L’actu-concurrence (Paris)
    France 3924 contributions 779696 visits

Quotation

Alain Ronzano, Exclusive distribution: The French Competition Authority issues a new decision sanctioning the maintenance, after the entry into force of the Lurel Act, of an exclusive import agreement in the overseas communities (bioMérieux, Guyana Medical Service), 29 May 2019, Concurrences N° 3-2019, Art. N° 90755, www.concurrences.com

Visites 245

All reviews